La Riva, Aníbal https://orcid.org/0000-0003-2198-833X
Perez-Soto, Rafael H.
Aulestia, Juan
Mocanu, Valentin
Barajas-Gamboa, Juan S.
Dang, Jerry
Strong, Andrew
Corcelles, Ricard
Kroh, Matthew
Romero-Velez, Gustavo
Navarrete, Salvador
Article History
Received: 28 March 2026
Accepted: 15 June 2026
First Online: 31 August 2026
Declarations
Disclosures: The ACS-NSQIP and the hospitals participating in the ACS-NSQIP are the source of the data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors. Aníbal La Riva, MD, Rafael H. Perez-Soto, MD, MSc, Juan Aulestia, MD, Valentin Mocanu, MD, PhD, Juan S. Barajas-Gamboa, MD, Jerry Dang, MD, PhD, Andrew Strong, MD, Ricard Corcelles, MD, Gustavo Romero-Velez, MD, and Salvador Navarrete, MD, have no conflict of interest or financial ties to disclose. Matthew Kroh, MD is Chief Medical Officer for Advanced and General Surgical Technologies for Medtronic.